MedTrace Logo

HYPONATREMIA IN COVID-19 PATIENTS

NCT04493268 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-07-30

No results posted yet for this study

Summary

SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.

Conditions

Sponsors & Collaborators

  • Hospital Nacional Profesor Alejandro Posadas

    lead OTHER

Principal Investigators

  • CARLOS EGHI, physician · University of Buenos Aires

Eligibility

Min Age
1 Month
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-07
Primary Completion
2020-07-20
Completion
2020-07-21

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493268 on ClinicalTrials.gov